Largest biotechnology: pharmaceutical preparations companies — Page 3
Every US-listed biotechnology: pharmaceutical preparations company we cover, 500 of them, ranked by market capitalisation, with revenue and earnings taken from their SEC filings.
Combined market cap
$5.231 T
5.3% of all US-listed value
Companies
500
Ranked #5 of 152 industries
Average
$10.462 B
Mean market cap per company
| # | Name | Market cap | Close | Session | Country |
|---|---|---|---|---|---|
| 201 | EvolusEOLS | $486.8M | $7.37 | +0.14% | United States |
| 202 | Crescent BiopharmaCBIO | $485.5M | $13.07 | +5.74% | United States |
| 203 | DiaMedica TherapeuticsDMAC | $467.5M | $8.67 | +10.16% | United States |
| 204 | OculisOCS | $461.3M | $7.49 | +2.32% | Switzerland |
| 205 | Ovid TherapeuticsOVID | $460.9M | $2.36 | +8.76% | United States |
| 206 | BlossomHill TherapeuticsBLSM | $457.7M | $14.40 | +1.70% | United States |
| 207 | KamadaKMDA | $453.0M | $7.85 | +3.15% | Israel |
| 208 | AltimmuneALT | $447.4M | $2.30 | +3.14% | United States |
| 209 | Prothena Corp PublicPRTA | $436.4M | $8.50 | +0.24% | United States |
| 210 | Assembly BiosciencesASMB | $431.4M | $21.19 | +5.11% | United States |
| 211 | ARS PharmaceuticalsSPRY | $426.6M | $4.29 | +1.42% | United States |
| 212 | Indaptus TherapeuticsINDP | $394.4M | $2.96 | +8.43% | United States |
| 213 | Capricor TherapeuticsCAPR | $384.3M | $6.61 | -0.60% | United States |
| 214 | Relmada TherapeuticsRLMD | $358.4M | $3.36 | +6.33% | United States |
| 215 | Atea PharmaceuticalsAVIR | $358.1M | $4.47 | +1.71% | United States |
| 216 | RezoluteRZLT | $357.9M | $3.70 | +0.00% | United States |
| 217 | Galectin TherapeuticsGALT | $346.7M | $3.43 | -1.86% | United States |
| 218 | Enanta PharmaceuticalsENTA | $339.9M | $11.67 | +2.28% | United States |
| 219 | Opus GeneticsIRD | $333.6M | $4.01 | +4.97% | United States |
| 220 | Emergent BioSolutionsEBS | $322.5M | $6.29 | -1.10% | United States |
| 221 | Turn TherapeuticsTTRX | $319.7M | $10.47 | -2.51% | United States |
| 222 | Contineum TherapeuticsCTNM | $318.3M | $8.46 | +13.71% | United States |
| 223 | Benitec BiopharmaBNTC | $315.3M | $9.04 | +8.13% | United States |
| 224 | Arcturus TherapeuticsARCT | $312.1M | $10.98 | +5.37% | Israel |
| 225 | Cypherpunk TechnologiesCYPH | $302.8M | $2.81 | +11.07% | United States |
| 226 | Fulcrum TherapeuticsFULC | $284.1M | $3.72 | +0.54% | United States |
| 227 | Prelude TherapeuticsPRLD | $281.7M | $3.53 | +4.13% | United States |
| 228 | VogenxVOGX | $278.5M | $18.75 | +17.78% | United States |
| 229 | Abeona TherapeuticsABEO | $263.0M | $4.60 | +4.31% | United States |
| 230 | Perspective TherapeuticsCATX | $262.5M | $2.30 | +5.02% | United States |
| 231 | Rocket PharmaceuticalsRCKT | $256.9M | $2.34 | +4.46% | United States |
| 232 | Q32 BioQTTB | $256.6M | $8.62 | +10.65% | United States |
| 233 | BioAge LabsBIOA | $255.2M | $5.56 | +11.42% | United States |
| 234 | Larimar TherapeuticsLRMR | $253.5M | $2.44 | +15.09% | United States |
| 235 | AC ImmuneACIU | $253.4M | $2.49 | +2.26% | Switzerland |
| 236 | Vanda PharmaceuticalsVNDA | $252.1M | $4.17 | +1.96% | United States |
| 237 | Bicycle TherapeuticsBCYC | $252.0M | $3.60 | +1.84% | United Kingdom |
| 238 | AmarinAMRN | $242.5M | $11.48 | -0.43% | Ireland |
| 239 | ImmuneeringIMRX | $241.3M | $3.73 | +1.91% | United States |
| 240 | Lifecore BiomedicalLFCR | $241.1M | $6.37 | -0.31% | United States |
| 241 | Greenwich LifeSciencesGLSI | $238.4M | $16.24 | +6.77% | United States |
| 242 | Lyell ImmunopharmaLYEL | $237.7M | $9.70 | +10.23% | United States |
| 243 | InflaRxIFRX | $226.9M | $1.54 | +6.21% | Germany |
| 244 | Siga TechnologiesSIGA | $226.3M | $3.15 | +0.32% | United States |
| 245 | Zentalis PharmaceuticalsZNTL | $226.3M | $2.39 | +3.91% | United States |
| 246 | Keros TherapeuticsKROS | $226.0M | $11.40 | +3.07% | United States |
| 247 | Natures Sunshine ProductsNATR | $223.6M | $12.71 | +1.27% | United States |
| 248 | MacrogenicsMGNX | $222.3M | $3.49 | +4.80% | United States |
| 249 | Pyxis OncologyPYXS | $220.0M | $1.84 | +4.54% | United States |
| 250 | BridgeBio Oncology TherapeuticsBBOT | $218.1M | $2.72 | -4.56% | United States |
| 251 | Sol-Gel TechnologiesSLGL | $215.5M | $65.81 | +1.28% | Israel |
| 252 | PepGenPEPG | $198.8M | $2.87 | +6.30% | United States |
| 253 | Camp4 TherapeuticsCAMP | $198.3M | $3.16 | +0.64% | United States |
| 254 | EvommuneEVMN | $195.3M | $5.38 | +2.09% | United States |
| 255 | ProQR TherapeuticsPRQR | $194.7M | $1.38 | +5.34% | Netherlands |
| 256 | Entrada TherapeuticsTRDA | $194.3M | $4.99 | +3.53% | United States |
| 257 | ADC TherapeuticsADCT | $194.1M | $1.52 | +5.56% | Switzerland |
| 258 | Cartesian TherapeuticsRNAC | $193.5M | $6.40 | +5.18% | United States |
| 259 | Yarrow BioscienceYARW | $188.0M | $20.21 | +1.15% | United States |
| 260 | Sionna TherapeuticsSION | $187.6M | $4.15 | +3.49% | United States |
| 261 | Eledon PharmaceuticalsELDN | $183.2M | $2.26 | +4.40% | United States |
| 262 | Whitehawk TherapeuticsWHWK | $181.9M | $3.19 | +5.98% | United States |
| 263 | Oramed PharmaceuticalsORMP | $172.6M | $4.15 | +2.22% | Israel |
| 264 | Akebia TherapeuticsAKBA | $171.3M | $0.62 | -9.12% | United States |
| 265 | Nervgen PharmaNGEN | $165.7M | $1.54 | +0.00% | Canada |
| 266 | AdageneADAG | $165.1M | $2.50 | +9.17% | China |
| 267 | NovaBridge BiosciencesNBP | $164.4M | $1.43 | +9.62% | China |
| 268 | Alx OncologyALXO | $154.9M | $1.24 | +8.77% | United States |
| 269 | Upstream BioUPB | $154.5M | $2.82 | +0.71% | United States |
| 270 | Satellos BioscienceMSLE | $148.5M | $7.00 | +8.70% | Canada |
| 271 | Journey MedicalDERM | $147.3M | $5.22 | +0.97% | United States |
| 272 | Veraxa Biotech AG - Post de-SPACVRXA | $142.8M | $1.01 | +1.00% | Switzerland |
| 273 | Jyong BiotechMENS | $141.4M | $1.86 | -3.63% | Taiwan |
| 274 | Korro BioKRRO | $139.0M | $9.44 | +5.95% | United States |
| 275 | Canton StrategicCNTN | $137.8M | $1.73 | +2.37% | United States |
| 276 | Atrium TherapeuticsRNA | $136.5M | $7.98 | +4.86% | United States |
| 277 | AN2 TherapeuticsANTX | $134.3M | $3.56 | +5.64% | United States |
| 278 | Organigram GlobalOGI | $132.1M | $0.94 | -0.60% | Canada |
| 279 | OrganogenesisORGO | $131.2M | $1.02 | +0.00% | United States |
| 280 | Tiziana Life SciencesTLSA | $128.5M | $1.01 | +0.00% | United Kingdom |
| 281 | Retension PharmaceuticalsRTSN | $127.5M | $16.18 | -0.92% | United States |
| 282 | NkartaNKTX | $124.6M | $1.74 | -0.57% | United States |
| 283 | Cue BiopharmaCUE | $123.8M | $17.04 | +5.97% | United States |
| 284 | Kazia TherapeuticsKZIA | $122.5M | $7.88 | +0.38% | Australia |
| 285 | Minerva NeurosciencesNERV | $120.8M | $2.53 | +9.05% | United States |
| 286 | BGM GroupBGM | $119.8M | $8.97 | +0.00% | China |
| 287 | Foghorn TherapeuticsFHTX | $119.4M | $2.01 | +7.49% | United States |
| 288 | Cumberland PharmaceuticalsCPIX | $119.3M | $7.96 | +18.81% | United States |
| 289 | Spruce BiosciencesSPRB | $118.5M | $41.23 | +2.05% | United States |
| 290 | NRX PharmaceuticalsNRXP | $113.4M | $2.62 | -0.38% | United States |
| 291 | GeneluxGNLX | $113.1M | $2.50 | +2.04% | United States |
| 292 | TuHURA BiosciencesHURA | $112.2M | $1.76 | -1.12% | United States |
| 293 | vTv TherapeuticsVTVT | $110.1M | $27.85 | +3.36% | United States |
| 294 | Unicycive TherapeuticsUNCY | $105.8M | $3.80 | +8.26% | United States |
| 295 | PMV PharmaceuticalsPMVP | $105.0M | $1.39 | +10.76% | United States |
| 296 | Inovio PharmaceuticalsINO | $104.4M | $1.01 | +1.00% | United States |
| 297 | ImmunicIMUX | $101.1M | $7.41 | +6.01% | United States |
| 298 | PDS BiotechnologyPDSB | $100.9M | $0.96 | +4.80% | United States |
| 299 | CellectisCLLS | $99.5M | $0.99 | +6.97% | France |
| 300 | Tonix PharmaceuticalsTNXP | $99.1M | $5.78 | +0.87% | United States |
Showing 201–300 of 500 companies. One row per company, with secondary share classes folded into their primary listing. Updated 22 Oct 2026.
Sectors biotechnology: pharmaceutical preparations companies sit in
Other industries
Semiconductors 100Computer Software: Programming Data Processing 77Computer Software: Prepackaged Software 233Computer Manufacturing 10Major Banks 243Industrial Machinery/Components 210Catalog/Specialty Distribution 30Business Services 92Commercial Banks 35Integrated oil Companies 16Auto Manufacturing 29Oil & Gas Production 116Department/Specialty Retail Stores 13Investment Bankers/Brokers/Service 69Real Estate Investment Trusts 175Beverages (Production/Distribution) 36Telecommunications Equipment 84Electric Utilities: Central 61Finance: Consumer Services 165Electronic Components 20Biotechnology: Biological Products (No Diagnostic Substances) 162Medical Specialities 44Consumer Electronics/Appliances 23Package Goods/Cosmetics 24All industries →
Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered: see methodology.